Medical Mycology

Papers
(The TQCC of Medical Mycology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)62
On the lineage of Aspergillus fumigatus isolates in common laboratory use60
CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris53
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation31
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group30
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification29
COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City25
Ebselen and diphenyl diselenide against fungal pathogens: A systematic review24
High detection rate of azole-resistantAspergillus fumigatusafter treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low 23
Emerging and future strategies in the management of recalcitrant Candida auris22
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients22
Filamentous growth is a general feature of Candida auris clinical isolates21
Clinical characteristics and risk factors for COVID-19-associated Candidemia21
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan20
Candida tropicalis RON1is required for hyphal formation, biofilm development, and virulence but is dispensable for N-acetylglucosamine catabolism18
A review of recent research on antifungal agents against dermatophyte biofilms18
Aspergillosis: Emerging risk groups in critically ill patients18
Farnesol: An approach on biofilms and nanotechnology17
Central nervous system candidiasis beyond neonates: Lessons from a nationwide study17
Whole genome sequencing confirms Candida albicans and Candida parapsilosis microsatellite sporadic and persistent clones causing outbreaks of candidemia in neonates16
Three-gene phylogeny of the genusArthroderma: Basis for future taxonomic studies16
Under nonlimiting iron conditions pyocyanin is a major antifungal molecule, and differences between prototypic Pseudomonas aeruginosa strains15
Paeonol alleviates dextran sodium sulfate induced colitis involving Candida albicans-associated dysbiosis15
Hmg1 mutations in Aspergillus fumigatus and their contribution to triazole susceptibility15
Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa15
Effect of zinc pyrithione shampoo treatment on skin commensal Malassezia15
Conventional therapy and new antifungal drugs against Malassezia infections15
A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status15
Oxidative stress induced by piperine leads to apoptosis in Candida albicans14
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections14
Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug14
Different repartition of the cryptic species of black aspergilli according to the anatomical sites in human infections, in a French University hospital13
Covid-19-associated fungal osteomyelitis of jaws and sinuses: An experience-driven management protocol13
Chromoblastomycosis in Latin America and the Caribbean: Epidemiology over the past 50 years13
Opportunistic yeast pathogenCandidaspp.: Secreted and membrane-bound virulence factors13
Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles13
A case-series of bloodstream infections caused by theMeyerozyma guilliermondiispecies complex at a reference center of oncology in Brazil13
The assimilation of different carbon sources in Candida albicans: Fitness and pathogenicity12
Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018)12
Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella11
The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis11
In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis11
Evaluating Candida albicans biofilm formation in silkworms11
Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis11
Silver chitosan nanocomposites as a potential treatment for superficial candidiasis11
Spread of Sporothrix spp. through respiratory droplets from infected cats: A potential route of transmission11
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms10
Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Cand10
We need to talk about Candida tropicalis: Virulence factors and survival mechanisms10
Risk factors for COVID-19 associated mucormycosis in India: A case control study9
Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort9
Role of the high-affinity reductive iron acquisition pathway of Candida albicans in prostaglandin E2 production, virulence, and interaction with Pseudomonas aeruginosa9
Prospective observational study of respiratory Aspergillus colonization or disease in patients with various stages of chronic obstructive pulmonary disease utilizing culture versus nonculture t9
8-Hydroxyquinoline 1,2,3-triazole derivatives with promising and selective antifungal activity9
Low rate of azole resistance in cases of avian aspergillosis in Germany9
Fungal asthma among Ugandan adult asthmatics9
Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern9
Candida auris and some Candida parapsilosis strains exhibit similar characteristics on CHROMagarTMCandida Plus9
Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis9
Diagnosis of mucormycosis using an intercalating dye-based quantitative PCR9
Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring9
Antifungal effect of anthraquinones againstCryptococcus neoformans: detection of synergism with amphotericin B9
Detection of anti-Histoplasma capsulatum antibodies and seroconversion patterns in critically ill patients with COVID-19: An underdiagnosed fungal entity complicating COVID-19?8
The skin mycobiome of an astronaut during a 1-year stay on the International Space Station8
Chronic pulmonary aspergillosis is common among patients with presumed tuberculosis relapse in Ghana8
First report and molecular prevalence of potential zoonoticEnterocytozoon bieneusiin Turkish tumbler pigeons (Columba livia domestica)8
Occurrence and molecular identification of zoonotic microsporidia in pet budgerigars (Melopsittacus undulatus) in Turkey8
Novel antifungal activity of oligostyrylbenzenes compounds on Candida tropicalis biofilms8
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients8
Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans8
Diphenyl diselenide and its interaction with antifungals against Aspergillus spp.8
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans8
Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia8
Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease8
Peptidorhamanomannan: A surface fungal glycoconjugate from Scedosporium aurantiacum and Scedosporium minutisporum and its recognition by macrophages8
Increased sensitivity of a new commercial reverse transcriptase-quantitative PCR for the detection of Pneumocystis jirovecii in respiratory specimens8
Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study8
A systematic review on distribution and antifungal resistance pattern of Candida species in the Indian population8
Occurrence and molecular characterization of Enterocytozoon bieneusi in wild and domestic animal species in Portugal7
Sociodemographic characteristics and spectrum of Malassezia species in individuals with and without seborrhoeic dermatitis/dandruff: A comparison of residents of the urban and rural populations7
Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub–Saharan Africa: a systematic review with meta-analysis and meta-regression7
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis7
Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease7
Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China7
Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil7
Four genomic clades of Candida auris identified in Canada, 2012–20197
Sporothrix brasiliensis on cats with skin ulcers in Southern Brazil7
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus6
Infection of bats with Histoplasma species6
Antifungal susceptibility of clinical Cryptococcus gattii isolates from Colombia varies among molecular types6
Bronchoalveolar lavage fluid IMMY Sona Aspergillus lateral-flow assay for the diagnosis of invasive pulmonary aspergillosis: a prospective, real life evaluation6
Comparing the phenotypic, genotypic, and proteomic identification of Trichosporon species: A globally emerging yeast of medical importance6
Factors associated with Pneumocystis colonization and circulating genotypes in chronic obstructive pulmonary disease patients with acute exacerbation or at stable state and their homes6
Prevalence of vulvovaginal candidiasis in Brazil: A systematic review6
Evaluation of the Vitek Ms system for the identification of filamentous fungi6
Distribution, trends, and antifungal susceptibility ofCandidaspecies causing candidemia in Japan, 2010–2019: A retrospective observational study based on national surveillance data6
Defining the relationship between phylogeny, clinical manifestation, and phenotype for Trichophyton mentagrophytes/interdigitale complex; a literature review and taxonomic recommendations6
Raw bovine milk as a reservoir of yeast with virulence factors and decreased susceptibility to antifungal agents6
Biofilm and hyphal inhibitory synergistic effects of phytoactives piperine and cinnamaldehyde against Candida albicans6
Virulence factors of Malassezia strains isolated from pityriasis versicolor patients and healthy individuals6
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a 6
A novel TaqMan qPCR assay for rapid detection and quantification of pro-inflammatory microalgae Prototheca spp. in milk samples6
Natural alkaloid tryptanthrin exhibits novel anticryptococcal activity6
Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera6
Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa5
Candida khanbhaisp. nov., a new clinically relevant yeast within theCandida haemuloniispecies complex5
The RNA helicase Ski2 in the fungal pathogen Cryptococcus neoformans highlights key roles in azoles resistance and stress tolerance5
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain5
Effects of lipopeptide biosurfactants on clinical strains of Malassezia furfur growth and biofilm formation5
Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents5
A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model5
A new pleosporalean fungus isolated from superficial to deep human clinical specimens5
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality5
The shift from pulmonary colonization to Pneumocystis pneumonia5
Sporotrichosis in dogs: epidemiological and clinical-therapeutic profile and the emergence of itraconazole-resistant isolates5
Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally5
Molecular epidemiology of aspergillosis in Magellanic penguins and susceptibility patterns of clinical isolates5
Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling5
Invasive mold infection of the gastrointestinal tract: A case series of 22 immunocompromised patients from a single academic center5
Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia5
One year later: The effect of changing azole-treated bulbs for organic tulips bulbs in hospital environment on the azole-resistant Aspergillus fumigatus rate5
Ethanol modulates the effector functions of human monocyte-derived macrophages in response toParacoccidioides brasiliensisyeast cells5
External ear canal mycobiome of some rabbit breeds5
Proteomic profiling ofaspergillus flavusendophthalmitis derived extracellular vesicles in anin-vivomurine model5
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale5
Serum total IgE may be a biomarker among chronic pulmonary aspergillosis patients with elevated serum total IgE levels: A cohort study with pathological evaluations5
Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis5
Cellular and molecular insights on the regulation of innate immune responses to experimental aspergillosis in chicken and turkey poults5
Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases5
Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review4
Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) under managed care: a clinical and environmental investigation in a French zoological park4
Evaluation of a Cryptococcus capsular polysaccharide detection FungiXpert LFA (lateral flow assay) for the rapid diagnosis of Cryptococcosis4
The importance of appropriate processing and direct microscopic examination for the timely diagnosis and management of invasive infections caused by filamentous fungi4
The natural occurring Y129F polymorphism in Rhizopus oryzae (R. arrhizus) Cyp51Ap accounts for its intrinsic voriconazole resistance4
Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis4
Anti-Candida auris activity in vitro and in vivo of micafungin loaded nanoemulsions4
Association of adverse effects with high serum posaconazole concentrations4
P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI)4
New multilocus sequence typing primers to enable genotyping of AD hybrids within the Cryptococcus neoformans species complex4
Intestinal mycobiome associated with diagnosis of inflammatory bowel disease based on tissue biopsies4
Clinical features of Talaromyces marneffei infection in HIV-positive and HIV-negative individuals: A retrospective study in southern China4
Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp acti4
Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis4
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale4
Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies4
Malassezia species: the need to establish epidemiological cutoff values4
Cavitary Coccidioidomycosis: Impact of azole antifungal therapy4
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis4
In vitro and in vivo efficacies of Dectin-1-Fc(IgG)(s) fusion proteins against invasive fungal infections4
Distribution and genotypic analysis of Enterocytozoon bieneusi from wild boars in Korea4
Ozonated oil is effective at killing Candida species and Streptococcus mutans biofilm-derived cells under aerobic and microaerobic conditions4
Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico4
Two novel species of Arthroderma isolated from domestic cats with dermatophytosis in the United States4
Clinical characteristics and risk factors for COVID-19-associated Candidemia4
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients4
Diagnostic evaluation of serum (1, 3)-β-d-glucan levels using the Fungitec G-Test MK kit for Pneumocystis jirovecii pneumonia (PCP) in non-HIV patients4
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility4
Corticosteroids alter alveolar macrophage control of Lichtheimia corymbifera spores in an ex vivo mouse model3
Coccidioidomycosis in patients with various inflammatory disorders treated with tumor necrosis factor α inhibitors3
Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases3
Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: Clinical features, risk factors, and posaconazole profiles3
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa3
It is still PCP that can stand for Pneumocystis pneumonia: Appeal for generalized use of only one acronym3
Madurella mycetomatis grains within a eumycetoma lesion are clonal3
Trichophyton tonsurans in Chile: Genotyping in search of an origin3
Elucidating the lactic acid tolerance mechanism in vaginal clinical isolates of Candida glabrata3
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia3
Aspergillusspp. osteoarticular infections: an updated systematic review on the diagnosis, treatment and outcomes of 186 confirmed cases3
CYP51A polymorphisms ofAspergillus fumigatusin lung transplant recipients: Prevalence, correlation with phenotype, and impact on outcomes3
Using MALDI-ToF mass spectrometry to identify mushroom species: Proof of concept analysis ofAmanitagenus specimens3
Assessment of panfungal PCR performance with formalin-fixed paraffin-embedded tissue specimens3
Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–20203
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database3
The fungal-specific subunit i/j of F1FO-ATP synthase stimulates the pathogenicity of Candida albicans independent of oxidative phosphorylation3
Outcome of patients with cystic fibrosis colonized byScedosporiumandLomentosporaspecies: A longitudinal cohort study3
Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain3
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants3
Clinical and microbiological features of candiduria in critically ill adult patients in Shiraz, Iran (2016–2018): deviations from international guidelines and fluconazole therapeutic failure3
The need for fast and accurate detection of dermatomycosis3
Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study3
RNAi machinery regulates nutrient metabolism and fluconazole resistance in the pathogenic fungusCryptococcus deneoformans3
Can bronchial secretion cultures identify the etiologic agent of COVID-19-associated pulmonary aspergillosis in ICU patients? Comparison with a species-specific Aspergillus PCR in serum3
Candida auris PCR for high-throughput infection control screening3
Limitations of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of Aspergillus species3
A Falciformispora senegalensis grain model in Galleria mellonella larvae3
Cryptococcus neoformans- andCryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia3
Cryptococcosis in Africa: What the data tell us3
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility3
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis3
Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis3
Isolation of a fungal calcineurin A mutant suggests that amoebae can counter-select virulence attributes of microbes3
iTRAQ-based proteomics revealed baicalein enhanced oxidative stress of Candida albicans by upregulating CPD2 expression3
Use of 1,3-beta-d-glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients3
Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance3
Investigation of the value of precipitins in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with a positive marker for Aspergillus species3
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series3
Influence of iron on growth and on susceptibility to itraconazole in Sporothrix spp3
High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin3
P142 Lodderomyces elongisporus: A n emerging cause of fung emia3
Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel2
Comparison of the characteristics of patients with invasive infections and noninvasive infections caused byTrichosporon asahii2
The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload2
Cryptococcus neoformans can utilize ferritin as an iron source2
Clinical predictive models of invasive Candida infection: A systematic literature review2
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger2
Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar2
SARS-CoV-19-associated Rhino-orbital and cerebral mucormycosis: clinical and radiological presentations2
Materials used to prevent adhesion, growth, and biofilm formation ofCandidaspecies2
The relationship between the preference of mating type (MAT) and source in the opportunistic pathogen Talaromyces marneffei2
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage2
Comparing the virulence of four major clades of Candida auris strains using a silkworm infection model: Clade IV isolates had higher virulence than the other clades2
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients2
Coccidioidomycosis in llamas and alpacas diagnosed at the University of California, Davis (1990–2016)2
Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing 2
The dog as a sentinel and animal model for coccidioidomycosis2
Pneumocystis jirovecii among patients with cystic fibrosis and their household members2
Proteomic perspective of azole resistance in Aspergillus fumigatus biofilm extracellular matrix in response to itraconazole2
Efficacy and safety of miconazole muco-adhesive tablet versus itraconazole in oropharyngeal candidiasis: A randomized, multi-centered, double-blind, phase 3 trial2
Characterization ofProtothecaCYP51/ERG11 as a possible target for therapeutic drugs2
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia2
Enterocytozoon bieneusi and Encephalitozoon intestinalis (microsporidia) in HIV-positive patients in central Spain2
Characterization of Cervus timorensis velvet antler and its effect on biofilm formation of Candida species2
Geotrichum spp: An overlooked and fatal etiologic agent in immunocompromised patients. A case series from a referral center in Mexico2
Incidence of invasive fungal infections in patients with hematological malignancies receiving ibrutinib therapy in south-east Austria2
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?2
Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin2
Effect of copper on the antifungal activity of disulfiram (Antabuse®) in fluconazole-resistant Candida strains2
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study2
False-positive galactomannan antigen testing in pulmonary nocardiosis2
P421 Whole-transcriptome analysis of Sporothrix brasiliensis grown in mold- and yeast-inducing conditions2
Association of semi-quantitative cryptococcal antigen results in plasma with subclinical cryptococcal meningitis and mortality among patients with advanced HIV disease2
P204 Secondary organizing pneumonia caused by Aspergillus flavus in immunocompromised patients2
Opaque cell-specific proteome ofCandida albicansATCC 102312
Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience2
P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases2
False positive Aspergillus galactomannan assay results caused by specific parenteral nutrition2
Saquinavir potentiates itraconazole’s antifungal activity against multidrug-resistant Candida auris in vitro andin vivo2
Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia2
Whole-genome sequencing ofCandida haemuloniispecies complex from Brazil and the United States: Genetic diversity and antifungal susceptibility2
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris2
Antifungal activity of deferiprone and EDTA against Sporothrix spp.: Effect on planktonic growth and biofilm formation2
Onychomycosis caused by the environmental mold Neoscytalidium dimidiatum in Colombia, and in vitro antifungal susceptibility evaluation2
In depth search of the Sequence Read Archive database reveals global distribution of the emerging pathogenic fungus Scedosporium aurantiacum2
A novel rat model of denture stomatitis and the role of antibiotics in the development of the disease2
Pneumocystis jirovecii and microsporidia: An unusual coinfection in HIV patients?2
The qualitative accuracy of clinical dermatophytes via matrix-assisted laser desorption ionization-time of flight mass spectrometry: A meta-analysis2
OUP accepted manuscript2
Human mucosal-associated invariant T cells respond to Mucorales species in a MR1-dependent manner2
Invasive bone and joint infections from the French Scedosporiosis/lomentosporiosis Observational Study (SOS) cohort: no mortality with long-term antifungal treatment and surgery2
fuPCR as diagnostic method for the detection of rare fungal pathogens, such as Trichosporon, Cryptococcus and Fusarium2
0.15082001686096